These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4060968)

  • 21. Role of serotonin in the regulation of growth hormone and prolactin secretion in the domestic fowl.
    Rabii J; Buonomo F; Scanes CG
    J Endocrinol; 1981 Sep; 90(3):355-8. PubMed ID: 6974213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression.
    Shapira B; Lerer B; Kindler S; Lichtenberg P; Gropp C; Cooper T; Calev A
    Br J Psychiatry; 1992 Feb; 160():223-9. PubMed ID: 1540763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.
    Palazidou E; Stephenson J; Butler J; Coskeran P; Chambers S; McGregor AM
    Psychopharmacology (Berl); 1995 Jun; 119(3):311-4. PubMed ID: 7675967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
    Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
    Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.
    Cowen PJ; Gadhvi H; Gosden B; Kolakowska T
    Psychopharmacology (Berl); 1985; 86(1-2):164-9. PubMed ID: 2991963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormone- and prolactin-secretion in the rat.
    Koenig J; Mayfield MA; Coppings RJ; McCann SM; Krulich L
    Brain Res; 1980 Sep; 197(2):453-68. PubMed ID: 6105900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of two serotonin antagonists on prolactin and thyrotrophin secretion in man.
    Ferrari C; Paracchi A; Rondena M; Beck-Peccoz P; Faglia G
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):575-78. PubMed ID: 991435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion.
    Di Renzo G; Amoroso S; Taglialatela M; Canzoniero L; Basile V; Fatatis A; Annunziato L
    Eur J Pharmacol; 1989 Mar; 162(2):371-3. PubMed ID: 2524399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
    Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of d-fenfluramine on anterior pituitary hormone release in the rat: in vivo and in vitro studies.
    Serri O; Rasio E
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2449-53. PubMed ID: 3449200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
    Losa M; Schopohl J; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):467-73. PubMed ID: 3929513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.
    Goldman JA; Molitch ME; Thorner MO; Vale W; Rivier J; Reichlin S
    J Endocrinol Invest; 1987 Aug; 10(4):397-406. PubMed ID: 3119697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impulsiveness and the prolactin response to d-fenfluramine.
    Evans J; Platts H; Lightman S; Nutt D
    Psychopharmacology (Berl); 2000 Apr; 149(2):147-52. PubMed ID: 10805609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyproheptadine stimulated prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; el Halawani ME
    Poult Sci; 1985 May; 64(5):1038-40. PubMed ID: 3158889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of 5-HT 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat.
    Willoughby JO; Menadue MF; Liebelt HJ
    Neuroendocrinology; 1988 Jan; 47(1):83-7. PubMed ID: 3340274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA; DeMeo MD; Sweeney JA; Halper J; Mann JJ; Shear MK
    Biol Psychiatry; 1992 Jan; 31(1):19-34. PubMed ID: 1311964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.